RARE, But Not Alone.
One Community, Breakthrough Impact
One Community, Breakthrough Impact
Earlier this year, the FDA approved Dupixent for bullous pemphigoid. This kind of breakthrough doesn’t just happen. It’s the result of years of work from patients, caregivers, researchers, and supporters like you. This is a milestone moment we should all celebrate!
More than a milestone...
This FDA approval is more than a milestone. It's an opportunity that can build momentum for future developments in both PEMPHIGOID and PEMPHIGUS.
Every gift gets us closer to the next breakthrough!
Rare, But Not Alone.
When a patient comes to the IPPF, our goal is to guide them through their journey of diagnosis, treatment, and managing their condition.
We provide a clear path through all the Who?, What?, When?, Where?, Why?, and How? questions so that people with pemphigus & pemphigoid can focus on healing.
One
Community.
Though pemphigus and pemphigoid are rare, there are tens-of-thousands of people affected by these diseases all around the world. You may be rare, but you're not alone.
One
Voice.
Together, we can't be ignored. The recent FDA approval generates new interest in P/P research. This community is being heard. Researchers and decision-makers now know: Progress is possible, and the patient voice is necessary to drive it forward.
Breakthrough
Impact.
Patients and caregivers; doctors and researchers; pharmaceutical companies and government. The IPPF exists to rally everyone behind a common goal: Breakthrough Impact for P/P patients.
